| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Endocrinology, Departments of Medicine and Pathology, University of Nijmegen Nijmegen, The Netherlands
Address requests for reprint to: A. G. H. Smals, Department of Medicine, Division of Endocrinology, University of Nijmegen, Nijmegen, The Netherlands.
Clinical and biochemical findings in 13 patients (11 women and 2 men) with macronodular adrenocortical hyperplasia (MNH; nodule size, >0.5 to 5.3 cm) were compared withthose of 18 patients (15 women and 3 men) with Cushing's disease and diffuse (n = 9) or micronodular (n = 9) hyperplasia (DH). All were bilaterally adrenalectomized for their hypercorticism. The clinical picture was almost identical in both groups, except for greater frequency of hypertension (13 of 13 us. 10 of 18; P < 0.05), alopecia (4 of 11 vs. 0 of 15; P < 0.05), and scintigraphic lateralization (6 of 7 vs. 1 of 7; P < 0.05) in the MNH group than in the DH group. The sella turcica was enlarged in 30% of the patients in both groups. Patients with MNH were significantly older than DH patients [43.5 ± 7.8 (mean± SD) vs. 31.7 ± 10.1 yr; P < 0.005] and had a 3-fold longer duration of disease (7.8 ± 4.6 vs. 2.0 ± 1.1 yr; P < 0.001) than those with DH. The mean plasma ACTH and cortisol levels and urinary 17-hydroxycorticosteroid excretion were elevated in both MNH and DH patients and responded similarly to specific (corticotropin-releasing hormone and metyrapone) and nonspecific (TRH and LHRH) stimuli. However, dexamethasone suppressibility and the stimulatory effect of ACTH on adrenocortical function were less in the MNH than in the DH group or its subgroups, suggestinga greater degree of adrenal autonomy in the former. Adrenal weight in MNH (15.8 ± 12.1 g each) was almost twice as high as in DH (8.2 ± 2.0 g) patients and positively correlated with the duration of the disease. The data suggest that MMH may be a resultof long-standing Cushing's disease with varying degrees of pituitary dependence and adrenocortical autonomy, which may lead to confusing biochemical and radiological findings. Bilateral adrenalectomy, rather than hypophysectomy, is the treatment of choice in MNH.
* Part of the study was presented at the 65th Annual Meeting of The Endocrine Society, San Antinio, TX, June 8-19, 1873 (Abstract 721).
Received April 15, 1983.
This article has been cited by other articles:
![]() |
A. G. Rockall, S. A. Babar, S. A. A. Sohaib, A. M. Isidori, S. Diaz-Cano, J. P. Monson, A. B. Grossman, and R. H. Reznek CT and MR Imaging of the Adrenal Glands in ACTH-independent Cushing Syndrome RadioGraphics, March 1, 2004; 24(2): 435 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Choyke and J. L. Doppman Case 18: Adrenocorticotropic Hormone-dependent Cushing Syndrome1 Radiology, January 1, 2000; 214(1): 195 - 198. [Full Text] |
||||
![]() |
J. M. Swain, C. S. Grant, R. T. Schlinkert, G. B. Thompson, J. A. vanHeerden, R. V. Lloyd, and W. F. Young Corticotropin-Independent Macronodular Adrenal Hyperplasia: A Clinicopathologic Correlation Arch Surg, May 1, 1998; 133(5): 541 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Orth Cushing's Syndrome N. Engl. J. Med., March 23, 1995; 332(12): 791 - 803. [Full Text] [PDF] |
||||
![]() |
L. M. Fig, M. D. Gross, B. Shapiro, D. A. Ehrmann, J. E. Freitas, D. E. Schteingart, G. M. Glazer, and I. R. Francis Adrenal Localization in the Adrenocorticotropic Hormone-Independent Cushing Syndrome Ann Intern Med, October 1, 1988; 109(7): 547 - 553. [Abstract] [PDF] |
||||
![]() |
P. B. Kaplowitz, R. Carpenter, H. H. Newsome Jr, and R. W. Downs Jr Cushing's Syndrome Resulting From Primary Pigmented Nodular Adrenocortical Disease Arch Pediatr Adolesc Med, October 1, 1986; 140(10): 1072 - 1075. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |